Form D · Biotechnology
PROTEOTECH INC
Kirkland, WA · CIK 0001072040
Offering snapshot reported Jun 27, 2011 · SEC filing
- Reported sold
- $10M Offering amount: $10.9M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 15, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 27, 2011 | Initial | $10,021,378 | No comparison | 1 | SEC filing |
| May 7, 2009 | Initial | $519,401 | No comparison | Not reported | SEC filing |
| Aug 11, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-161887
Issuance of equity upon conversion of outstanding notes--no additional funds received.
Source: Form D, filed Jun 27, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William T Frantz | Director |
| Dennis L Mc Curley | Director, Executive |
| Stephen Runnels | Director, Executive |
| Alan D Snow | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12040 115 Th Ave Ne
Kirkland, WA, 98034
Kirkland, WA, 98034